Healthcare Foresights has released a comprehensive report on the Anesthesia and Respiratory Devices Market, which was valued at approximately USD 57.2 billion in 2025 and is projected to reach USD 100.5 billion by 2035, reflecting a CAGR of 5.8% from 2026 to 2035. This growth is driven by the increasing prevalence of respiratory diseases, the rising number of surgical procedures, and advancements in technology, particularly in home healthcare settings.

The report highlights the critical role of anesthesia and respiratory devices in ensuring patient safety and effective management during surgical procedures and respiratory care. Key components of anesthesia devices, such as machines, vaporization systems, and airway management tools, facilitate the controlled administration of anesthetics and support vital functions. Respiratory devices, including ventilators, nebulizers, and oxygen concentrators, are essential for assisting or replacing patient breathing, especially in chronic conditions like COPD and asthma. The shift towards homecare and ambulatory services is further accelerating the adoption of these technologies, as patients and caregivers seek more user-friendly and portable solutions.

A significant implication of this report is its potential to reshape research and development strategies in the field. The emphasis on home healthcare and the demand for advanced, compact devices may prompt biotech firms to prioritize innovation in device design and functionality. This shift could lead to accelerated timelines for the development of next-generation anesthesia and respiratory technologies, ultimately enhancing patient outcomes and expanding access to care in non-traditional settings.

Source: globenewswire.com